CAREDX, INC. CDNA Cash Flow

Caredx, inc. (CDNA)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Operating activities:
Net loss
-20,260	-21,968	-20,946	-39,103	-45,318	-46,781	-74,655	-68,972	-58,945	-55,560	-39,640	-29,154	-35,613	-39,756	-28,809	-28,496	-21,187	-13,707	-8,950	-4,249	-187	781	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
20,623	22,417	19,070	14,966	12,485	7,138	5,506	4,075	2,059	1,744	1,803	2,072	1,943	1,998	1,824	1,461	1,507	1,341	1,213	1,042	767	535	0	0	0
Amortization of deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	45	58	102	117	130	816	763	739	727	0	0	0
Revaluation of common stock warrant liability to estimated fair value
2,923	319	1,548	-19,891	-27,308	-22,978	-50,758	-42,264	-32,429	-29,622	-1,875	8,110	3,878	-250	0	0	0	-	-	-	-	-	0	0	0
Amortization of inventory fair market value adjustment
-	-	-	-	-	234	313	437	550	418	1,766	3,120	4,207	4,175	0	0	0	-	-	-	-	-	-	-	-
Depreciation and amortization
5,981	5,523	5,016	4,570	4,337	4,215	4,026	3,931	3,832	3,727	3,465	3,644	3,593	2,920	2,416	1,535	892	796	733	648	571	512	0	0	0
Amortization of right-of-use assets
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revaluation of contingent consideration to estimated fair value
400	210	0	0	873	1,017	1,888	2,482	1,545	1,180	275	-431	-464	-456	-92	-325	-86	-126	-419	-1,350	-1,492	-1,239	0	0	0
Loss on conversion of JGB Debt to shares of common stock
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and noncash interest expense
-	-	-	-	-	2,232	2,868	3,815	4,909	3,452	2,317	1,612	485	-101	397	-147	-119	247	211	900	1,053	799	0	0	0
Non-cash goodwill impairment
-	-	-	-	-	-	-	-	-	1,958	14,979	14,979	14,979	13,021	0	0	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
7,547	12,675	7,953	7,643	6,143	3,967	3,623	2,237	139	109	-1,421	-1,877	-616	-1,047	816	1,643	718	-320	492	-19	-299	417	0	0	0
Inventory
2,241	1,270	1,322	521	205	-363	-921	-1,106	-751	-1,025	-629	-508	-791	-492	-374	-201	-179	80	319	117	49	168	0	0	0
Prepaid and other assets
833	829	-238	425	533	502	27	191	349	84	522	35	-191	-999	-860	-130	80	823	242	-1,734	-1,080	310	0	0	0
Operating leases liabilities, net
-1,723	-1,854	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
3,557	1,351	1,698	2,922	-1,452	-168	-771	65	745	292	570	138	-1,058	-620	-1,292	269	1,067	489	1,097	-729	589	510	0	0	0
Accrued compensation
1,450	3,115	1,953	1,724	1,400	4,291	4,049	2,237	572	1,065	545	452	870	977	998	354	313	682	789	861	469	298	0	0	0
Accrued royalties
-	-	-	-	-	-	-	-	-	-	-	-	-	21	58	-8	-23	1	-45	-3,257	-2,549	-2,563	0	0	0
Accrued and other liabilities
2,875	3,029	2,767	1,854	277	719	54	-450	-971	-1,233	-3,555	-2,968	-2,123	-105	3,134	3,119	3,444	1,240	742	-1,479	-2,103	364	0	0	0
Change in deferred revenue
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Change in deferred taxes
1,337	1,280	1,593	1,232	1,525	1,607	2,574	2,438	2,164	2,088	1,075	1,882	1,611	1,340	0	0	0	-	-	-	-	-	-	-	-
Net cash used in operating activities
43	-2,769	312	106	-5,356	-4,007	-8,155	-10,774	-12,084	-14,307	-15,218	-14,201	-17,072	-16,523	-17,438	-19,264	-14,930	-9,752	-6,498	-7,130	-4,544	-3,350	0	0	0
Purchase of property and equipment, net
0	-	0	0	0	-	0	0	180	-	22	367	508	549	703	742	944	1,199	1,523	1,302	1,078	733	0	0	0
Net cash used in investing activities
-23,740	-22,579	-22,197	-19,296	-7,718	-7,929	-12,005	-12,366	-6,791	-6,105	-996	-372	-21,080	-21,121	-21,270	-21,309	-944	-1,199	-1,717	-1,526	-1,678	-1,333	0	0	0
Financing activities:
Perceptive term loan issuance costs
-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock under employee stock purchase plan
777	760	1,015	596	596	287	33	82	82	94	93	173	173	304	0	0	0	-	-	-	-	-	-	-	-
Taxes paid related to net share settlement of restricted stock units
3,282	4,153	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in short-term credit facility
-	-	-	-	-	-677	-1,258	-853	-225	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash collateral for debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Proceeds from exercise of warrants
300	100	100	10,581	11,075	11,000	11,954	1,513	1,014	989	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
2,343	3,553	4,136	4,070	2,765	1,480	851	441	342	262	10	10	13	19	10	13	41	46	59	56	26	19	0	0	0
Restricted cash on operating leases
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Proceeds from debt, net of issuance costs
-	-	-	-	-	-	-	-	-	24,002	0	0	0	-	-	-	-	15,625	10,643	10,643	15,625	0	0	0	0
Principal payments on debt and finance lease obligations
175	172	16,820	16,824	26,498	28,089	12,504	12,837	3,077	14,359	15,026	16,583	16,843	3,944	2,185	-26	-222	11,466	12,749	14,425	15,776	4,528	0	0	0
Net cash used in financing activities
-179	-132	37,098	46,550	51,898	50,268	30,876	20,786	15,930	29,379	9,325	15,903	35,893	24,927	27,047	20,840	641	4,408	3,121	37,678	40,370	35,986	0	0	0
Effect of exchange rate changes on cash and cash equivalents
-1,314	-849	-429	-59	-102	2	148	120	106	106	7	36	100	83	0	0	0	-	-	-	-	-	-	-	-
Net decrease in cash, cash equivalents and restricted cash
-25,190	-26,329	14,784	27,301	38,722	38,334	10,864	-2,234	-2,839	9,073	-6,882	1,366	-2,159	-12,634	-11,689	-19,750	-15,233	-6,543	-5,094	29,022	34,148	31,303	0	0	0
Deferred purchase consideration
-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Allenex [Member]
Acquisition of Allenex AB
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Allenex AB [Member]
Acquisition of business and noncontrolling interests, net of cash acquired
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conexio
Contingent payments related to acquisition
173	225	246	250	264	225	171	91	13	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-